Cell context-dependent activities of parthenolide in primary and metastatic melanoma cells

Transcriptional control of the melanoma malignant phenotype

(2010) Vladislava O. Melnikova et al.   CANCER BIOLOGY & THERAPY

Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro

(2010) Karolina Lesiak et al.   MELANOMA RESEARCH

Inhibition of NF-kB and metalloproteinase-9 expression and secretion by parthenolide derivatives

(2009) Mario Dell’Agli et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

A non-apoptotic function of caspase-3 in pharmacologically-induced differentiation of K562 cells

(2009) M Sztiller-Sikorska et al.   BRITISH JOURNAL OF PHARMACOLOGY

Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression

(2009) C Riganti et al.   BRITISH JOURNAL OF PHARMACOLOGY

Understanding Melanoma Signaling Networks as the Basis for Molecular Targeted Therapy

(2009) Keiran S.M. Smalley   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide

(2009) Z. Liu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Parthenolide inhibits proliferation of vascular smooth muscle cells through induction of G0/G1 phase cell cycle arrest

(2009) Shao-xiang Weng et al.   Journal of Zhejiang University-SCIENCE B

Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy

(2009) J. Yang et al.   MOLECULAR CANCER THERAPEUTICS

Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions

(2009) Y.N. V. Gopal et al.   MOLECULAR CANCER THERAPEUTICS

Pharmacologic inhibitors of I B kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo

(2009) A. I. Idris et al.   MOLECULAR CANCER THERAPEUTICS

Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach

(2009) Brian T. Kawasaki et al.   PROSTATE

STI571/doxorubicin concentration-dependent switch for diverse caspase actions in CML cell line K562

(2008) Malgorzata Czyz et al.   BIOCHEMICAL PHARMACOLOGY

Wild-type p53 in cancer cells: When a guardian turns into a blackguard

(2008) Ella Kim et al.   BIOCHEMICAL PHARMACOLOGY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Role of Parthenolide in Intracellular Signalling Processes: Review of Current Knowledge

(2008) Luis Bedoya et al.   Current Signal Transduction Therapy

A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes

(2008) Yang Liu et al.   JOURNAL OF CONTROLLED RELEASE

KINK-1, a Novel Small-Molecule Inhibitor of IKKβ, and the Susceptibility of Melanoma Cells to Antitumoral Treatment

(2008) Margarete Schön et al.   JNCI-Journal of the National Cancer Institute

Is NF-κB a good target for cancer therapy? Hopes and pitfalls

(2008) Véronique Baud et al.   NATURE REVIEWS DRUG DISCOVERY

Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation

(2008) Yeriel Estrada et al.   Pigment Cell & Melanoma Research